echoloc
Get started
echoloc/ Companies/ Sequel Med Tech

Sequel Med Tech Tech Stack

Insulin pump manufacturer scaling toward IPO

Medical Equipment Manufacturing Manchester, NH 201–500 employees Founded 2023 Privately Held
sequelmedtech.com LinkedIn

Sequel Med Tech is a recently founded (2023) medical device company building insulin pumps and adjacent diabetes-care products. The tech stack reveals a finance-heavy infrastructure play—Snowflake, dbt, Airbyte, Databricks, BigQuery, NetSuite, and SOX compliance tooling (Purview, Entra)—suggesting a company in active preparation for public markets. Active projects (IPO readiness, SOX internal controls, cost accounting system) and pain points (compliance, scaling accounting processes, succession pipeline) confirm they're in hypergrowth mode with governance and operational architecture as near-term priorities.

Tech Stack 29 technologies

Core StackSalesforce Snowflake MuleSoft AWS Apex dbt Airbyte Python Apache Airflow Databricks BigQuery Redshift WordPress JavaScript NetSuite Power Platform Power Automate Lightning Lightdash Salesforce Marketing Cloud Webflow Drupal AMPscript HTML/CSS Google Analytics 4 SuiteScript Entra PowerShell Purview

What Sequel Med Tech Is Building

◆Challenges

  • Improving product development
  • Timely medical information delivery
  • Preparing for ipo
  • Scaling accounting processes
  • Ensuring compliance with sox
  • Expanding market penetration
  • Scaling talent strategy for growth
  • Succession pipeline development
  • Support growth and long-term scalability
  • Scalable processes from the ground up

▲Active Projects

  • Launch new insulin pump
  • Future sequel product launches
  • Product training webinars
  • Future sequel products
  • Standard medical response document development
  • Medical information repository maintenance
  • Medical education content development
  • Ipo readiness and compliance
  • Cost accounting system implementation
  • Sox internal controls design

Hiring Activity

Accelerating20 roles · 15 in 30d

Department

Sales
9
Healthcare
6
HR
2
Finance
1

Seniority

Senior
13
Manager
2
Director
1
Mid
1
VP
1
Company intelligence

Find more companies like Sequel Med Tech by tech stack, pain points and active projects

Get started free

About Sequel Med Tech

Sequel Med Tech designs and manufactures insulin pumps and related diabetes-management devices. Based in Manchester, New Hampshire, the company was founded in 2023 and currently employs 201–500 people. The hiring pattern is skewed heavily toward sales (9 open roles) and healthcare (6 roles), with significant investment in leadership across finance, HR, and operations—typical of a medical device firm scaling from product-market fit toward regulatory and commercial scale. Active projects span product launches, medical education content, and infrastructure for compliance and accounting; pain points center on IPO preparation, SOX controls, and the operational systems required to support sustained growth.

HeadquartersManchester, NH
Company Size201–500 employees
Founded2023
Hiring MarketsUnited States

Frequently Asked Questions

What tech stack does Sequel Med Tech use?

Sequel uses Salesforce (core + Marketing Cloud), Snowflake, BigQuery, Databricks, dbt, Airbyte, and Lightdash for data; AWS for infrastructure; NetSuite for ERP; and Microsoft stack (Entra, Power Platform, Purview) for identity and compliance.

Where is Sequel Med Tech headquartered?

Manchester, New Hampshire. All current hiring is sourced in the United States.

Similar Companies in Medical Equipment Manufacturing

Other companies in the same industry, closest in size

H
Haemonetics
Medical Equipment Manufacturing
C
CMR Surgical
Medical Equipment Manufacturing
S
Sol-Millennium Medical Group
Medical Equipment Manufacturing
C
Ceribell │ AI-Powered Point-of-Care EEG
Medical Equipment Manufacturing

How this profile is built

Sequel Med Tech's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.